1156 related articles for article (PubMed ID: 11797019)
21. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
[TBL] [Abstract][Full Text] [Related]
22. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
23. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
24. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
25. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
26. [Fibrinolysis system in patients with sepsis in state of myelotoxic agranulocytosis].
Galstian GM; Krechetova AV; Vasil'ev SA; Orel EB; Pustovoĭt LA; Egorova EO; Saridi EIu; Gemdzhian EG; Gorodetskiĭ VM
Anesteziol Reanimatol; 2012; (2):41-8. PubMed ID: 22834287
[TBL] [Abstract][Full Text] [Related]
27. Inflammation-induced systemic proteolysis of inter-alpha-inhibitor in plasma from patients with sepsis.
Balduyck M; Albani D; Jourdain M; Mizon C; Tournoys A; Drobecq H; Fourrier F; Mizon J
J Lab Clin Med; 2000 Feb; 135(2):188-98. PubMed ID: 10695665
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
29. Activation of the fibrinolytic system in patients with fulminant liver failure.
Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
[TBL] [Abstract][Full Text] [Related]
30. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
[TBL] [Abstract][Full Text] [Related]
31. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
32. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
[TBL] [Abstract][Full Text] [Related]
33. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
34. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.
Nanninga PB; van Teunenbroek A; Veenhof CH; Büller HR; ten Cate JW
Thromb Haemost; 1990 Nov; 64(3):361-4. PubMed ID: 1710832
[TBL] [Abstract][Full Text] [Related]
35. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
36. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
37. Fibrinolytic and procoagulant activity in septic and haemorrhagic shock.
Helling H; Schenk HJ; Pindur G; Weinrich M; Wagner B; Stephan B
Clin Hemorheol Microcirc; 2010; 45(2-4):295-300. PubMed ID: 20675912
[TBL] [Abstract][Full Text] [Related]
38. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome.
Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG
Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792
[TBL] [Abstract][Full Text] [Related]
39. [Abnormalities in coagulation and fibrinolysis in septic shock with purpura].
Sánchez Miralles A; Reig Sáenz R; Marco Vera P; Muñoz Pérez F; Alvarez Sánchez B; Sebastián Muñoz I
An Esp Pediatr; 2002 Feb; 56(2):99-103. PubMed ID: 11827669
[TBL] [Abstract][Full Text] [Related]
40. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
